<DOC>
	<DOCNO>NCT02292303</DOCNO>
	<brief_summary>The main objective clinical get information pharmacokinetics zinc-enriched yeast.The bioavailability yeast enrich zinc compare two select zinc salt use food supplement zinc oxide zinc gluconate .</brief_summary>
	<brief_title>Clinical Trial Determine Bioavailability Three Different Zinc Preparations</brief_title>
	<detailed_description />
	<mesh_term>Zinc Oxide</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>Subject able willing sign Informed Consent Form prior screen evaluation Sex : female ( premenopausal ) , male Age : 20 50 year BMI ≥19 ≤30 kg/m² Nonsmoker Subject good physical mental health establish medical history , physical examination , electrocardiogram , vital sign , result biochemistry , hematology Relevant history presence medical disorder , potentially interfere trial For trial clinically relevant abnormal laboratory , ECG , vital sign physical finding screen Migraine regular headache , intense premenstrual symptom Coffee consumption &gt; 3 cup / day Blood donation within 2 month prior trial start trial Regular intake mineral supplement within 4 week prior trial start trial Chronic intake substance affect intestinal absorption zinc Vegetarians / vegan Drug , alcohol medication abuse Known HIVinfection Known acute chronic hepatitis B C infection Relevant allergy know hypersensitivity compound study preparation , example lactose intolerance Known pregnancy , breast feeding intention become pregnant study Participation another clinical trial within last 4 week concurrent participation another clinical trial Not anticipate plan change lifestyle duration study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Zinc/pharmacokinetics</keyword>
</DOC>